The Director, Global IBD Portfolio and Growth Strategy is responsible for informing commercial prioritization of our company's IBD pipeline and product development priorities for pre-clinical and clinical-stage assets within the immunology portfolio.
Base: $190,800.00 - $300,300.00; Bonus/Equity: Eligible for annual bonus and long-term incentive; Benefits: Comprehensive package including medical, dental, vision, retirement, paid holidays, vacation, sick days
Must-have
Nice-to-have
Not specified